ARQIS advises Inflexion on the acquisition of Primed from Paragon Partners

16. July 2026

ARQIS provided legal advice to the private equity firm Inflexion on its acquisition of Primed from Paragon Partners. The global market for single-use medical consumables is large and growing, giving Primed a strong platform to expand further in Germany and internationally. Under Inflexion's ownership, Primed will continue to invest in its core product range, accelerate product development and drive further growth in its sterilisation business. Inflexion will support management in accelerating international expansion through targeted acquisitions and investments in commercial capabilities, strengthening Primed's direct access to customers in key markets. The investment reflects Inflexion's commitment to partnering with leading local healthcare businesses and supporting their long-term success. The transaction marks Inflexion’s sixth investment in the DACH region, made through Inflexion’s Buyout Fund VI and is subject to the usual regulatory approvals.

Founded in 1946 and headquartered in Halberstadt, Germany, Primed designs, manufactures and distributes certified single-use medical consumables. The business employs more than 450 people across a vertically integrated platform spanning the full value chain, from compounding to final sterile product. Its MDR-certified products are used in over 70 countries, supplying hospitals and medical care facilities. Primed also operates HA2, one of Europe's largest medical sterilisation platforms.

Inflexion is a leading European private equity firm. The Inflexion funds, with offices in London, Manchester, Amsterdam, Stockholm and Frankfurt/Main, invest in a wide range of industries. The current investment is being made by Buyout Fund VI and is the third healthcare investment in the DACH region, following Proteros and Tierarzt Plus Partner.

An ARQIS team headed by Dr. Jörn-Christian Schulze provided legal advice to Inflexion on this transaction. This is another occasion on which Inflexion has relied on ARQIS for legal advice. In the past, the team headed by Dr. Schulze advised the Welsh darts equipment manufacturer Nodor Group — in which Inflexion Private Equity Partners holds a majority stake — on its acquisition of Autodarts GmbH and advised Inflexion on its acquisition of the finanzen.net Group from Axel Springer. As with the acquisition of the finanzen.net Group, ARQIS advised Inflexion alongside a team from Latham & Watkins.

Advisor to Inflexion Private Equity Partners

ARQIS (Dusseldorf): Core Deal Team: Dr. Jörn-Christian Schulze (Lead Partner), Christos Choudeloudis (Managing Associate), Steffen Schubert, Stella Tönnessen (both Associates, all Transactions), Dr. Friedrich Gebert (Partner), Dr. Bernhard Gröhe (Managing Associate, both Regulatory), Partner: Thomas Chwalek (Transactions), Johannes Landry (Financing), Dr. Ulrich Lienhard (Real Estate), Tobias Neufeld (Tech Law), Marcus Nothhelfer (IP, Munich), Counsel: Dr. Maximilian Backhaus (Transactions), Christian Judis (Compliance, Munich), Jens Knipping (Tax), Nora Stratmann (Commercial, Munich), Martin Weingärtner (HR Law), Managing Associates: Tim Bresemann (Real Estate), Johanna Klingen (Tech Law), Marius Mesenbrink (Japan Desk), Rolf Tichy (IP, Munich), Paul Vermeulen (Dispute Resolution), Associates: Rebecca Gester (Commercial, Munich), Paulina Hüttner, Dr. Julia Wildgans (both IP, both Munich), Solonga Meyer (Regulatory, Berlin), Anna Munsch, Dr. Tim Weill (both HR Law), Foreign Lawyer: Qing Xia (Transactions)